Background and Purpose-An individualized risk score for the development of stroke may be a useful tool to motivate patients to modify their risk behaviors. We developed and validated a point-based prediction model (risk score) for stroke incidence using a Japanese cohort of general men and women. Methods-The Japan Public Health Center-based prospective study cohort II (age range, 40-69 years at baseline in 1993-1994; n=15 672) was used to derive the point-based model according to Cox regression results. The model was externally validated using the Japan Public Health Center study cohort I and also by bootstrap methods within cohort II. The model discrimination was evaluated by the area under the receiver operating characteristic curve, model calibration, by the Grønnesby-Borgan χ 2 statistic. Vascular age was also calculated. Results-During 14 years of follow-up, 790 incident stroke cases occurred. Variables selected for the model were age, sex, current smoking, body mass index, blood pressure, antihypertensive medication use, and diabetes mellitus. Interactions of sex with current smoking and of antihypertensive medication use with systolic blood pressure were statistically significant. The point-based model discriminated reasonably well (area under the receiver operating characteristic curve, 0.73). The area under the receiver operating characteristic curve of the point-based model applied externally to cohort I was reasonably good: 0.69. A 50-year-old man with diabetes mellitus and hypertension has an estimated vascular age of 69 years. High normal blood pressure and grade 1 hypertension accounted for one third of the stroke incidence. Conclusions-We developed score to predict 10-year stroke risk using variables that are easily available in the community setting. (Stroke. 2013;44:00-00.) (M.I.). See list of all JPHC study participants is given in the online-only Data Supplement. The online-only Data Supplement is available with this article at http://stroke.ahajournals.org/lookup/suppl/
S troke often results in physical or cognitive impairment, making it a leading cause of severe disability requiring long-term care. 1 It is, therefore, fundamentally important to prevent the occurrence of stroke. In clinical practice or community screening settings, stratifying individuals by the predicted risk of developing stroke could be important to efficiently and effectively deliver individualized interventions. Indeed, guidelines from the American Heart Association and the National Cholesterol Education Program Adult Treatment Panel III use projected absolute risk of future cardiovascular disease (CVD) or coronary heart disease (CHD) to consider antiplatelet therapy or to target low-density lipoprotein level interventions. 2, 3 However, stroke generally has not been included as an outcome for these guidelines. 4 Furthermore, although the US Preventive Services Task Force recommends aspirin therapy for women based on the risk of stroke, 5 prediction models for stroke are much less available than those for CHD, [6] [7] [8] [9] probably because of limited relevance of such models in the US, where CHD has been the leading public health problem. However, a stroke-specific model would especially be useful in Asia where stroke is more common than CHD. 10 In this study, we also considered it important to develop better tools to communicate stroke risk to patients to motivate them to modify their behaviors or to receive appropriate pharmacological interventions. 11 Although the assessment of cardiovascular risk itself is useful to assist decision-making regarding pharmacological treatment, the presentation of absolute risk directly to patients is of questionable benefit because most high relative risk individuals have low absolute risk, particularly when they are young. 12, 13 Therefore, we also estimated vascular age according to the points developed in the present analysis. No studies have calculated vascular age for stroke risk, although some have for CHD risk. 14, 15 The aim of the present study was to develop a point system to estimate 10-year risk of stroke incidence using a large community-based sample of Japanese men and women, where the incidence of stroke is high. We included baseline antihypertensive medication use and lifestyle information (physical activity and alcohol drinking) in the development of the point system. Furthermore, we externally and internally validated the prediction model.
Methods

Study Cohort
The Japan Public Health Center study cohorts were established in 1990 (cohort I) and 1993 to 1994 (cohort II) in 9 public health-center areas throughout Japan initially enrolling 116 896 individuals. 16 The study population was defined as all residents with Japanese nationality aged 40 to 59 years (in cohort I, n=54 479) or aged 40 to 69 years (in cohort II, n=61 984). In the present study, we used the cohort I as a validation cohort because of the narrower age range at baseline. We excluded those with missing information on their lifestyle (n=11 185) or missing biochemical data (n=34 489). From the remaining 16 310 participants, those with a history of CVD (n=638) were excluded, leaving 15 672 (men, n=5315; women, n=10 357) for the analysis. The study protocol, including the informed consent procedure of the Japan Public Health Center study, was approved by the Human Ethics Review Committees of the National Cancer Center and Osaka University.
Follow-up
The subjects were followed up from the date of the baseline survey through 2007. Residence and survival were ascertained annually using residential registries maintained by each municipality. Of the nondeceased participants (n=13 655), 792 (6%) moved out of the study area, but only 51 (0.4%) had unknown vital status (loss to follow-up). In Japan, residency and death registration are required by law, and these registries are believed to be complete. Information on the cause of death was obtained through the death certificate provided by the Ministry of Health, Labor, and Welfare after the Ministry of Internal Affairs and Communications granted permission.
Ascertainment of Stroke
A total of 78 hospitals located in the sampling areas of the study cohort were systemically surveyed for the occurrence of stroke. These are major hospitals capable of treating patients with stroke. Medical records of possible stroke hospitalizations were reviewed by physicians, who were blinded to the exposures. In addition, we sent 5-and 10-year follow-up questionnaires to participants to complete the surveillance for nonfatal stroke and reviewed death certificate diagnoses systematically. The response rates of the 5-and 10-year follow-up questionnaire were 82% and 78%, respectively. Medical records of these events were also collected and reviewed.
Strokes were confirmed according to National Survey of Stroke criteria, which require a constellation of neurological deficits of sudden or rapid onset lasting at least 24 hours or until death. 17, 18 For each subtype of stroke, hemorrhagic (intraparenchymal hemorrhage or subarachnoid hemorrhage) or ischemic (thrombotic or embolic stroke), a definite diagnosis was established based on the examination of computed tomography scans, magnetic resonance images, or autopsy. In this study, we defined strokes as hemorrhagic and ischemic strokes.
Baseline Measurements
A self-administered questionnaire was used to assess smoking and drinking habits, and physical activity. The amount of alcohol consumption was estimated using responses to the question items on frequency, usual daily amount, and type of alcohol beverages. Sport activity was assessed as the frequency (almost never, 1-3 days/mo, 1-2 days/wk, 3-4 days/wk, and almost daily) of participation in nonoccupational physical activity. We selected leisure-time activity because it would be more modifiable and was included in the American Heart Association's guideline. 19 Height in stocking feet and weight in light clothing were measured, and body mass index was calculated as weight (kg) divided by the square of the height in meters (m 2 ). Arterial blood pressure (BP) was measured using a standard mercury sphygmomanometer applied to the right arm of the seated participant after a 5-minute rest. Serum total and high-density lipoprotein cholesterol and glucose were measured in 23 laboratories. The precision and accuracy of lipid measurement in all laboratories were satisfactory, according to the Osaka Medical Center for Health Science and Promotion, a member of the cholesterol Reference Method Laboratory Network.
Variables
The following variables were initially used to derive the prediction model. Age was categorized into six 5-year age groups (40-44 [reference], 45-49, 50-54, 55-59, 60-64, and 65-69) . Smoking status was dichotomized (current, nonsmoker [reference]). Alcohol consumption was grouped according to usual ethanol consumption (0-149 [reference], 150-299, ≥300 g/wk). Ethanol consumption of 150 g/wk is approximately equivalent of 1 can of beer or 1 serving of sake (Japanese wine) per day. Frequency of sports activity was assessed and categorized into 3 groups (almost none, 1-3 days/mo, 1-2 days/wk, or more [reference]). Body mass index was divided into 3 categories (<25 [reference], 25-29.9, and ≥30) . BP was categorized into 6 groups according to the Japanese Society of Hypertension 2009 guideline, 20 which is consistent with the European Society of Hypertension/Cardiology 2007 guideline. 21 The reference category (optimal) was defined as systolic BP (SBP) <120 mm Hg and diastolic BP (DBP) <80 mm Hg. Other BP categories were defined in the following order: normal, SBP<135 and DBP<85; highnormal, SBP<140 and DBP<90; grade I hypertension, SBP<160 and DBP<100; grade II hypertension, SBP<180 and DBP<110; and grade III hypertension, SBP≥180 or DBP≥110 mm Hg. Total cholesterol was grouped into 4 groups: <5.2 [reference], 5.2 to <5.7, 5.7 to <6.2, and 6.2 mmol/L or higher. High-density lipoprotein was also categorized into 3 groups (<1.0, 1.0 to <1. 3, 1.3, or higher [reference] ). Three glucose level categories were defined: <5.6 (fasting) or 7.8 mmol/L (nonfasting) [reference], 5.6 to <7.0 (fasting) or 7.8 to <11.1 mmol/L (nonfasting), and ≥7.0 (fasting) or 11.1 mmol/L or higher (nonfasting). 22 Individuals in the last category were considered to have diabetes mellitus. Those using glucose-lowering medications with glucose <5.6 (fasting) or 7.8 mmol/L (nonfasting) were classified in the intermediate category. Otherwise, those on glucose-lowering medications were diabetes. Antihypertensive medication use was recorded, and the interaction term between BP and antihypertensive medication was tested and included. The validity of questionnaire items has been reported. [23] [24] [25] [26] 
Statistical Analysis
All analyses were conducted using SAS for Windows, version 9.3 (SAS Institute, Cary, NC). Univariate analyses of these variables with stroke were performed first using Cox proportional hazards models. Significant (P<0.10) risk factors from the univariate models were then pooled into a single multivariate Cox model, and a backward by guest on April 9, 2017 http://stroke.ahajournals.org/ Downloaded from selection procedure was used to determine final model, retaining significant (P<0.10) predictors. 27 Because the intermediate glucose category was not statistically significant, it was collapsed with the reference category. All possible interactions of risk factors with sex were tested, and significant interactions (P<0.05) were included in the final model. The proportional hazards assumption was confirmed graphically by examining whether the ln (-ln) survival curves were parallel for each level of predictors in the multivariate model as well as by models including interaction terms between follow-up time and each predictor.
Then, we assigned points associated with each level of significant predictors by the method used by the Framingham Study. 28 The 10-year We calculated a point total for all participants in the data set using the point system. The discrimination of both the Cox regression model and the point-based model was estimated using the area under the receiver operating characteristic curve (AUC) based on a method to estimate with time-dependent AUC for long-term risk prediction. The calibration, a measure of the goodness of model fit, was assessed by comparing the observed and predicted number of events in deciles of predicted risk, as calculated by the Grønnesby-Borgan χ 2 statistic. For external validation, we also calculated a point total for cohort I participants (n=3454, number of incident strokes=165) using the pointbased model derived from cohort II and calculated the AUC and the Grønnesby-Borgan χ 2 statistic. Then, 100 bootstrap samples were generated, sampling subjects with replacement, to conduct an internal validation of our point system. Bootstrapping methods provide more stable estimates with a lower bias compared with other methods of internal validation. However, because we used the same cohort to generate the 100 bootstrap samples for validation of the point system that we had used to develop the point, we adjusted our AUC obtained from the internal validation for optimism. We used methods and SAS macros used in the Atherosclerosis Risk in Communities (ARIC) Study. 29 Subsequently, we used the point system to calculate vascular age, which is the chronological age of a person at certain predicted risk who have all risk factors at ideal levels. 15 In addition, we estimated the population attributable fraction (PAF) as p multiplied by [(hazard ratio for a category being considered − hazard ratio for the reference category)/ hazard ratio for the category being considered], where p is the proportion of cases that are exposed in whichever category is being considered. 30
Results
During the 201 971 person-years of follow-up among the initially 40-to 69-year olds of cohort II, 790 incident stroke events were recorded (crude incidence rate, 3.9 per 1000 person-years). Univariate analyses of baseline variables identified 10 potential risk factors (Table 1) for stroke incidence. However, alcohol intake, physical activity, and high-density lipoprotein cholesterol were eliminated from the final multivariate model by the backward variable selection procedure. In contrary, interactions of sex with smoking status and of antihypertensive medication use with BP categories remained statistically significant in the model. All the risk factors in the final model and the points derived for each category are shown in Table 2 . Current smoking women were assigned more points than were smoking men (8 vs 4) . Points derived for BP categories in individuals taking antihypertensive medication were similar (10-11 points), except for those with grade III hypertension (SBP/DBP, 180/110 mm Hg or higher) (15 points). The 10-year predicted probability of incident stroke by total points (score) is presented in Table 3 along with the corresponding vascular ages. Furthermore, the change in the 10-year predicted risk of stroke with aging for a man with an ideal risk factor profile is graphically simulated (solid line, Figure 1 ). The vascular age of a man at certain 10-year risk is determined from this line. For example, a 69-year-old man with ideal risk factor profile has a 10-year stroke risk of 0.05; the vascular age of this man is 69 years. Differences in the predicted risk for a hypothetical man with grade I hypertension not taking antihypertensive medication (dashed line), or with hypertension and diabetes mellitus (dotted line), but otherwise ideal status, are overlaid in Figure 1 . Because a 50-year-old man with hypertension and diabetes mellitus has the 10-year stroke risk of 0.05, the man's vascular age is elevated to 69 years. The AUC of the final Cox model (0.74) indicated good discrimination. The numbers of predicted stroke events generally matched the numbers of observed strokes events in 10-year risk deciles (Figure 2 ; Grønnesby-Borgan, P=0.62). The AUC of the point-based score was 0.73 that was significantly lower than that of the Cox model. However, the calibration of the point-based system was still good (Grønnesby-Borgan, P=0.28). When we applied the present point-based system to cohort I participants, the AUC was lower (0.69) possibly attributable, in part, to a narrower age range. However, the calibration of the score was good (Grønnesby-Borgan χ 2 test, P=0.17). The internal validation of the point system, using 100 bootstrap samples adjusted for optimism revealed an AUC of 0.73 (95% confidence interval, 0.72-0.75), indicating that the point system should perform well in subjects from populations similar to the Japan Public Health Center study.
The PAF of a risk factor represents the proportion of cases that might be prevented by eliminating the risk factor. Current smoking had an estimated PAF for incident stroke of 13.8% in men and 1.3% in women (Table 4) . Similarly, the PAFs for overweight/obesity and diabetes mellitus were 6.1% and 5.4%, respectively. In contrast, the PAF of incident stroke for hypertension (≥140/90 mm Hg) was 35.4%.
Discussion
We developed a point system to predict 10-year risk of stroke in Japanese men and women aged 40 to 69 years. We also presented vascular age, which has been shown to be useful for helping younger individuals with high relative but low absolute risk to appreciate CVD risk. The discrimination of the point-based model was reasonably good (AUC, 0.73) and comparable with that for U.S. older people (AUC, 0.73) 31 but was lower than that for Chinese (AUC, 0.77). 7 The Chinese study (240 stroke cases out of 3513 men and women) used similar variables to ours, but their final model did not include smoking, body mass index, or antihypertensive medication, but included SBP, DBP, diabetes mellitus, family history of stroke, and atrial fibrillation. Our Cox model initially included alcohol drinking, physical activity, and total and high-density lipoprotein cholesterol in addition to these variables. The previous studies included subjects with a history of other CVDs, who were excluded in the present study. We also externally validated the model, using cohort I of the Japan Public Health Center study; validation was not done in the previous studies.
For public health considerations, we presented PAFs according to the categories derived for the point system. Hypertension was estimated to account for more than one third of the stroke events in this cohort, far outweighing other risk factors.
We found a significant interaction of antihypertensive medication use with BP categories. Namely, those on antihypertensive medication had higher than expected 
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May 2013 stroke risk than those without, when their BPs were optimal, normal, high normal, and grade 1 hypertension categories. Previous observational studies, unlike clinical trials, have also found residual cardiovascular risk in treated hypertensive subjects. [32] [33] [34] Antihypertensive medication use in observational studies probably indicates more severe hypertension, not just the effect of treatment. In addition, the period during which antihypertensive medication has been used as well as the age at which the treatment was initiated could also contribute to the apparent risk. Of course, the prevention of hypertension and nonpharmacological control of BP to optimal levels are considered preferable to antihypertensives. For women, the hazard ratio of stroke with current smoking was significantly higher than for men (interaction, P<0.05) as was suggested by a previous investigation. 35 Although smoking women were assigned a double score (8 vs 4) compared with smoking men, the PAF related to women's smoking was much lower (13.8% vs 1.3%) attributable to low prevalence of smoking in Japanese women.
Strengths of the present study include its large sample size in a population where stroke incidence is high, the use of state-of-art methods to evaluate the performance of prediction models, the validation in the other cohort, the presentation of vascular age to aid risk communication, and the inclusion of PAF analysis to inform public health. The PAF analysis has confirmed the importance of addressing untreated high normal and grade 1 hypertension to reduce stroke incidence rates in the community. Finally, because the risk factors for the prediction model could be obtained without laboratory testing, if diabetes mellitus history were used instead of blood test-defined diabetes mellitus. That would make the score The PAF represents the proportion that might be prevented by eliminating a risk factor. NA indicates not applicable for the PAF analysis, because sex is not modifiable. Subtotal of PAF was calculated as the sum of PAFs for categories within the variable. PAF indicates population attributable fraction.
by guest on April 9, 2017 http://stroke.ahajournals.org/ Downloaded from potentially usable in low-resource healthcare settings in Africa and Asia where stroke burden is disproportionately high. 36, 37 There are limitations that warrant consideration. First, stroke subtypes were not separately analyzed. Although stroke pathogenesis is heterogeneous even among ischemic strokes, many risk factors are the same for all subtypes; therefore, we reasoned that a prediction model for total stroke would be useful. Indeed, lacunar stroke is quite common in Japan, 38 which pathophysiologically resembles intraparenchymal hemorrhage, because of its small-vessel pathology. Second, change in the behaviors (smoking status) or drug treatment (initiation/termination) during follow-up was not considered. 39 It would be possible that stroke risk related to current smoking is underestimated if current smokers at baseline quit smoking during follow-up. Also, medical treatment of hypertension has improved during the follow-up. 40 It is likely that more individuals would be under good control with newer antihypertensive medications. Furthermore, cardiovascular protective effects may be larger in newer medications. Because patients/clients should be informed as precisely as possible about the attainable risk reduction by lifestyle modification or drug treatment, this is an important area of future investigation. Third, use of medication for antihypertensive or diabetes mellitus was self-reported. However, a validation study in another setting in Japan reported high level of self-report accuracy. 41 Fourth, atrial fibrillation was not included in the models. Because it is a strong predictor of ischemic stroke, its inclusion may improve performance of the prediction model. However, because it is so strong a predictor, individuals with clinically overt atrial fibrillation would usually be under strict medical control; therefore, its inclusion in the prediction model may not be so clinically useful. Nevertheless, future study with atrial fibrillation information is needed to clarify these issues. Fifth, the sample actually analyzed in the present study was older and more likely to be women than those excluded because of missing values. Therefore, caution is needed to generalize the present findings especially regarding the PAF. Finally, the sample included only Japanese aged 40 to 69 years. It is ideal to include young individuals because it would be reasonable to consider risk factor modification as early as possible, and some of the risk factors (smoking, obesity, and high BP) are already prevalent before middle age. Furthermore, pattern of CVD in Japanese is somewhat peculiar as characterized by low incidence of CHD and high incidence of stroke. 42, 43 Therefore, recalibration and validation may be necessary before applying to other populations with different pattern of CVD incidence.
In conclusion, the present study developed, calibrated, and validated a point-based prediction model for 10-year stroke risk using a large population-based cohort of Japanese men and women. Whether the use of the prediction model for risk stratification and the presentation of vascular age would be helpful to modify behaviors and prevent stroke incidence would need to be tested in a future clinical trial.
